Stella Bowcock

1.6k total citations
43 papers, 727 citations indexed

About

Stella Bowcock is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Stella Bowcock has authored 43 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 14 papers in Oncology and 8 papers in Genetics. Recurrent topics in Stella Bowcock's work include Multiple Myeloma Research and Treatments (18 papers), Cancer Treatment and Pharmacology (6 papers) and Neutropenia and Cancer Infections (4 papers). Stella Bowcock is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Cancer Treatment and Pharmacology (6 papers) and Neutropenia and Cancer Infections (4 papers). Stella Bowcock collaborates with scholars based in United Kingdom, United States and India. Stella Bowcock's co-authors include C.E.M. Griffiths, Helen L. Richards, Brian Kirby, Caitlin Jacobs Martin Main, Dónal G. Fortune, R. Cheingsong‐Popov, Jonathan Weber, A. Aronstam, C Panagiotidi and Daniel Catovsky and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Stella Bowcock

39 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stella Bowcock United Kingdom 13 254 216 159 116 102 43 727
Josette Champagne Canada 15 326 1.3× 288 1.3× 134 0.8× 148 1.3× 151 1.5× 26 896
W Stangel Germany 14 153 0.6× 218 1.0× 28 0.2× 50 0.4× 48 0.5× 42 839
Susana Castañón Spain 15 76 0.3× 76 0.4× 135 0.8× 80 0.7× 44 0.4× 24 735
Serdal Korkmaz Türkiye 12 146 0.6× 81 0.4× 78 0.5× 191 1.6× 80 0.8× 63 626
Caroline Dupont France 12 43 0.2× 68 0.3× 27 0.2× 214 1.8× 76 0.7× 27 897
Ilan Asher Israel 15 22 0.1× 223 1.0× 51 0.3× 28 0.2× 62 0.6× 37 571
Gregory Bagby United States 10 28 0.1× 262 1.2× 9 0.1× 46 0.4× 88 0.9× 15 595
Beata Seeber Austria 18 144 0.6× 320 1.5× 30 0.2× 42 0.4× 126 1.2× 49 1.2k
Jutte van der Werff ten Bosch Belgium 15 123 0.5× 193 0.9× 61 0.4× 113 1.0× 210 2.1× 57 671

Countries citing papers authored by Stella Bowcock

Since Specialization
Citations

This map shows the geographic impact of Stella Bowcock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella Bowcock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella Bowcock more than expected).

Fields of papers citing papers by Stella Bowcock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stella Bowcock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella Bowcock. The network helps show where Stella Bowcock may publish in the future.

Co-authorship network of co-authors of Stella Bowcock

This figure shows the co-authorship network connecting the top 25 collaborators of Stella Bowcock. A scholar is included among the top collaborators of Stella Bowcock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella Bowcock. Stella Bowcock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shrestha, Roshi, et al.. (2023). Patient-reported symptoms and diagnostic journey in Multiple Myeloma. Frontiers in Oncology. 13. 1282569–1282569.
3.
Ramasamy, Karthik, Ross Sadler, Alison Turner, et al.. (2022). Immune response to COVID ‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response. British Journal of Haematology. 197(3). 293–301. 14 indexed citations
4.
Buazon, April, Jennifer Vidler, Sam Norton, et al.. (2022). High numbers of COVID-19 patients transit through non-COVID wards, and associated healthcare workers have high infection rates: An observational cross-sectional study. PLoS ONE. 17(10). e0275154–e0275154. 1 indexed citations
5.
Heaney, Jennifer, Gulnaz Iqbal, Janet Dunn, et al.. (2020). Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study. SHILAP Revista de lepidopterología. 7(10). 1–70. 2 indexed citations
6.
Atkin, Catherine, Gulnaz Iqbal, Tim Planche, et al.. (2020). Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial. British Journal of Haematology. 192(6). 997–1005. 5 indexed citations
7.
Heaney, Jennifer, Gulnaz Iqbal, Janet Dunn, et al.. (2020). Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management. Blood Cancer Journal. 10(11). 114–114. 6 indexed citations
8.
Marcus, Robert, Stella Bowcock, Stephen Devereux, et al.. (2017). Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre study. Leukemia & lymphoma. 58(9). 2051–2056. 8 indexed citations
9.
Bowcock, Stella, et al.. (2011). Repeat haematinic requests in patients with previous normal results: the scale of the problem in elderly patients at a district general hospital. International Journal of Laboratory Hematology. 33(6). 610–613. 4 indexed citations
10.
Bowcock, Stella, C D Shee, Saad M. B. Rassam, & Peter Harper. (2004). Chemotherapy for cancer patients who present late. BMJ. 328(7453). 1430–1432. 5 indexed citations
11.
Thornton, Patrick, Estella Matutes, Andrew G. Bosanquet, et al.. (2003). High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities. Annals of Hematology. 82(12). 759–765. 76 indexed citations
12.
Cheingsong‐Popov, R., C Panagiotidi, Stella Bowcock, et al.. (1990). Antibodies to HIV-1 nef (p27): Prevalence, Significance, and Relationship to Seroconversion. AIDS Research and Human Retroviruses. 6(9). 1099–1105. 31 indexed citations
13.
Bowcock, Stella, D. A. G. Galton, & J M Goldman. (1989). Marrow aplasia developing 3 years after treatment with busulphan for chronic myeloid leukaemia. European Journal Of Haematology. 42(5). 496–497. 3 indexed citations
14.
15.
Brito‐Babapulle, F., Stella Bowcock, Robert Marcus, et al.. (1989). Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis. British Journal of Haematology. 73(1). 76–81. 65 indexed citations
16.
Dokal, Inderjeet, et al.. (1989). Major surgery in von Willebrand's disease. Clinical & Laboratory Haematology. 11(3). 205–211.
17.
Bowcock, Stella, et al.. (1988). Fatal splenic sequestration in adult sickle cell disease. Clinical & Laboratory Haematology. 10(1). 95–99. 6 indexed citations
18.
Hewitt, Patricia E., et al.. (1988). A prospective study of the incidence of delayed haemolytic transfusion reactions following peri‐operative blood transfusion. British Journal of Haematology. 69(4). 541–544. 19 indexed citations
19.
Bowcock, Stella, David C. Linch, Samuel J. Machin, & J W Stewart. (1987). Pyrimethamine in the myeloproliferative disorders: a forgotten treatment?. Clinical & Laboratory Haematology. 9(2). 129–136. 6 indexed citations
20.
Bowcock, Stella, et al.. (1984). Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy.. BMJ. 288(6434). 1879–1879. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josette Champagne Breakdown of academic impact, for papers by W Stangel Breakdown of academic impact, for papers by Susana Castañón Breakdown of academic impact, for papers by Serdal Korkmaz Breakdown of academic impact, for papers by Caroline Dupont Breakdown of academic impact, for papers by Ilan Asher Breakdown of academic impact, for papers by Gregory Bagby Breakdown of academic impact, for papers by Beata Seeber Breakdown of academic impact, for papers by Jutte van der Werff ten Bosch
Rankless by CCL
2026